Antimicrobial Gene Mining via Clone Coverage Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for identifying antimicrobial genes in microbial genomes face challenges, particularly in cloning toxic genes into E. coli, which are often unclonable due to their negative effects on bacterial growth, and existing techniques struggle to detect genes with low clone coverage that may encode toxic proteins or RNAs.

Innovation Solution

A method involving read mapping, clone coverage calculation, genomic region identification, toxicity level determination, and experimental validation to identify antimicrobial genes in microbial genomes by focusing on regions with low or zero clone coverage, which are likely to contain highly toxic genes, and subsequent experimental testing of these genes for bactericidal or bacteriostatic effects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If toxic genes are cloned into E. coli for study, then gene function can be investigated, but the genes are unclonable due to their negative effects on bacterial growth

Engineering Contradiction:
Improvegene cloning successVSAvoidtoxicity to E. coli
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent applies preliminary action by analyzing clone coverage data from genome sequencing before attempting to clone genes. By identifying regions with low or zero clone coverage in advance, researchers can predict which genes are likely toxic and avoid cloning them into E. coli, thus preventing the harmful effect before it occurs.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses clone coverage data as an intermediary indicator to indirectly identify toxic genes without directly testing them in E. coli. This intermediary approach allows prediction of gene toxicity based on sequencing data patterns, avoiding the need to actually clone and test potentially harmful genes in the host organism.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Loss of information

If conventional sequencing methods are used, then genome data can be obtained, but genes with low clone coverage that encode toxic proteins are difficult to detect

Engineering Contradiction:
Improvedetection of toxic genesVSAvoidclone coverage analysis
Core Design Contradiction:
Loss of informationVSDifficulty of detecting and measuring

Solution Approach 1:

The patent implements feedback by using clone coverage data from genome sequencing to identify and prioritize toxic genes for further study. The low clone coverage regions serve as feedback signals that indicate the presence of toxic genes, guiding researchers to focus their attention on these specific genomic regions rather than treating all genes equally.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent applies local quality by analyzing clone coverage at specific genomic regions rather than uniformly across the entire genome. By identifying localized regions with low or zero clone coverage, the method concentrates investigative resources on specific areas most likely to contain toxic genes, improving detection efficiency.

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS10227630B2Antimicrobial agents from microbial genomes
Publication Date: 2019.03.12 RGT UNIV OF CALIFORNIA
  • US10227630B2 patent drawing
  • US10227630B2 patent drawing
  • US10227630B2 patent drawing

AI summary

We describe a method for mining microbial genomes to discover antimicrobial genes and proteins having broad spectrum of activity. Also described are antimicrobial genes and their expression products from various microbial genomes that were found using this method. The products of such genes can be used as antimicrobial agents or as tools for molecular biology.